Rivaroxaban plus aspirin, compared with aspirin alone, reduced cardiovascular events in patients with stable peripheral or carotid artery disease, but increased the risk of major bleeding

Mant, J. (2018, October 1). Rivaroxaban plus aspirin, compared with aspirin alone, reduced cardiovascular events in patients with stable peripheral or carotid artery disease, but increased the risk of major bleeding. BMJ Evidence-Based Medicine. BMJ Publishing Group. https://doi.org/10.1136/bmjebm-2018-110899